Hi All,
really great announcement & Quarterly. Dimerix continue to move forward professionally & are always a step ahead of the game. It was a bit of a surprise the mention of commercial quantity batches of DMX-200 from their GMP facility, well that it is lined up & ready to go. Maybe that “expected to be available on the market within 2 years” comment on recent news coverage isn’t far off the mark. I guess DXB had to put out that ANN that they had not supplied a definitive timeframe, but there is the reality, it’s on the cards already.
I also had read about Takeda/Shire Possible T/O. Shire has a much bigger pipe line & I think the interest in that was for cancer. Something IMU ppl should be watching (I know there are quite a few of us here), because gastric cancer is prevalent in Asia & we are waiting on news from HER-Vaxx trials & this was one of the cancers targeted by Shire.
@Prestonian, cleaning up the share registry, Bingo on voting rights. You always think critically & appreciate your posts.
The other interesting thing to note is that PIQ-ASX recently announced that they have patented Pro-Marker D technology in Japan, which Dimerix will be using in their trials to monitor patients bloods. It’s also predictive of future CKD, so this is a fantastic partnership & diagnostic tool that Dimerix have cutting edge advantage over competitors. Watch this space & as BT pointed out, Takeda are already using & have used DXB HIT Receptor platform successfully. Takeda TO wouldn’t surprise me at all, however I do believe there will be US interest as well, with their huge CKD/Diabetes costs. We are in a fairly unique position here & yes patience is the key for SH.
I’m taking a break from HC for a while. Will discuss when we have things to talk about & that’s it. No one had posted on here the connection with PIQ patent & Japan as far as I could see from a quick read, so just wanted to add that FYI for all the wonderful LT holders here. Wise words from BT, set & forget...is what I have done also. Maybe a few more at 11-12c..lol.
To @stradzz, I’m so sorry to hear you lost your brother to cancer. You must have already been going through a tough time already. If I said anything to upset you, for that I’m truly sorry. You don’t know what’s going on in people’s lives, I know a lot of VETs can’t bring themselves to go to ANZAC marches & that’s fine, sometimes the memories are too raw & difficult, for whatever reason. I hope you are ok. <3
Catch up when we have some awesome news to discuss. :)
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Review & Appendix 4C
Ann: Quarterly Review & Appendix 4C, page-19
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add DXB (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $269.6M |
Open | High | Low | Value | Volume |
46.0¢ | 50.5¢ | 46.0¢ | $2.255M | 4.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 21052 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.490 |
1 | 38000 | 0.485 |
2 | 19350 | 0.480 |
2 | 114893 | 0.470 |
2 | 14280 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 21052 | 1 |
0.500 | 106103 | 3 |
0.505 | 100000 | 1 |
0.510 | 129000 | 3 |
0.515 | 160650 | 4 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |